GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Soiken Holdings Inc (TSE:2385) » Definitions » EBIT

Soiken Holdings (TSE:2385) EBIT : 円-610 Mil (TTM As of Jun. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Soiken Holdings EBIT?

Soiken Holdings's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2024 was 円-50 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was 円-610 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Soiken Holdings's annualized ROC % for the quarter that ended in Jun. 2024 was -10.62%. Soiken Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -15.63%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Soiken Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 42.31%.


Soiken Holdings EBIT Historical Data

The historical data trend for Soiken Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Soiken Holdings EBIT Chart

Soiken Holdings Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,047.73 916.79 1,208.77 725.72 -610.01

Soiken Holdings Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -58.90 -501.03 45.95 -105.23 -49.69

Competitive Comparison of Soiken Holdings's EBIT

For the Biotechnology subindustry, Soiken Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Soiken Holdings's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Soiken Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Soiken Holdings's EV-to-EBIT falls into.



Soiken Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-610 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Soiken Holdings  (TSE:2385) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Soiken Holdings's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=-198.752 * ( 1 - -3.01% )/( (1907.365 + 1946.607)/ 2 )
=-204.7344352/1926.986
=-10.62 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6977.552 - 132.77 - ( 4937.417 - max(0, 622.736 - 6736.501+4937.417))
=1907.365

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6946.134 - 209.503 - ( 4790.024 - max(0, 680.389 - 6765.144+4790.024))
=1946.607

Note: The Operating Income data used here is four times the quarterly (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Soiken Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-198.752/( ( (51.67 + max(1176.348, 0)) + (20.316 + max(1294.731, 0)) )/ 2 )
=-198.752/( ( 1228.018 + 1315.047 )/ 2 )
=-198.752/1271.5325
=-15.63 %

where Working Capital is:

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(317.34 + 1147.615 + 334.129) - (132.77 + 0 + 489.966)
=1176.348

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(428.934 + 1120.869 + 425.317) - (209.503 + 0 + 470.886)
=1294.731

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Soiken Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=-610.008/-1441.775
=42.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Soiken Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Soiken Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Soiken Holdings Business Description

Traded in Other Exchanges
N/A
Address
1-4-2 Shinsenri-Higashimachi, 13th Floor, Senri Life Science Center, Toyonaka, Osaka, JPN, 560-0082
Soiken Holdings Inc operates as a biotechnology company in Japan. It provides clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers. It is involved in the marketing research and post-marketing surveillance of health supplements.

Soiken Holdings Headlines

No Headlines